Clinical Trials

103 studies in Gastroenterology and Hepatology

  1. A Double Blind Placebo-Controlled Trial of Eflornithine and Sulindac to Prevent Recurrence of High Risk Adenomas and Second Primary Colorectal Cancers in Patients With Stage 0-III Colon Cancer, Phase III - Preventing Adenomas of the Colon With Eflornithine and Sulindac (PACES)
    1. Minnesota
  2. High Resolution Optical Imaging of Barrett s Esophagus Using Nvision Volumetric Laser Endomicroscopy (VLE)
    1. Florida
  3. A Phase II/III Trial of Neoadjuvant FOLFOX With Selective Use of Combined Modality Chemoradiation Versus Preoperative Combined Modality Chemoradiation for Locally Advanced Rectal Cancer Patients Undergoing Low Anterior Resection With Total Mesorectal Excision
    1. Minnesota
  4. Technical Success, Safety, and Short-term Efficacy for MR-Guided Laser Ablation of Hepatic Tumors
    1. Minnesota
  5. A Randomized, Global, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Once-daily Oral Avatrombopag for the Treatment of Adults With Thrombocytopenia Associated With Liver Disease Prior to an Elective Procedure
    1. Minnesota
  6. A Phase 1, Multicenter, Open-label Study to Determine the Safety and Pharmacokinetics of MMX Mesalamine Following Administration in Children and Adolescents With Ulcerative Colitis
    1. Minnesota
  7. Familial Barrett's Esophagus
    1. Minnesota
  8. Randomized Phase II Trial of Aspirin and Difluoromethylornithine (DFMO) in Patients at High Risk of Colorectal Cancer
    1. Minnesota
  9. A Phase Ib Clinical Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Advanced Gastrointestinal Cancer
    1. Arizona,
    2. Minnesota
  10. A Phase I Trial of Single Agent Trametinib (GSK1120212) in Advanced Cancer Patients With Hepatic Dysfunction
    1. Florida,
    2. Minnesota
  1. Prev
  2. 3
  3. 4
  4. 5
  5. 6
  6. 7
  7. Next